Adaptive planning using megavoltage fan-beam CT for radiation therapy with testicular shielding

Medical Dosimetry

Volumn 37, Issue 2, 2012, Pages 157-162

  Yadav, Poonam ^a,b   Kozak, Kevin ^a   Tolakanahalli, Ranjini ^a   Ramasubramanian, V ^b   Paliwal, Bhudatt R ^a,c   Welsh, James S ^a   Rong, Yi ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b VIT UNIVERSITY   (India)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Adaptive radiotherapy; Dose verification; Megavoltage CT imaging; Testicular shielding

Indexed keywords

ACCURACY; ADAPTIVE PLANNING; ADULT; ARTICLE; ARTIFACT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMUR; FEMUR HEAD; HUMAN; IMAGE ANALYSIS; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MEGAVOLTAGE FAN BEAM COMPUTER ASSISTED TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SHIELD; SARCOMA; TESTICULAR SHIELDING; TOMOTHERAPY; TREATMENT PLANNING;

HUMANS; LEAD; MALE; NERVE SHEATH NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SARCOMA; TESTICULAR DISEASES; THIGH; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84860495087     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2011.06.005     Document Type: Article

References (24)

1. Antolak J.A., Strom E.A. Fetal dose estimates for electron-beam treatment to the chest wall of a pregnant patient. Med. Phys. 1998, 25:2388-2391.
2. Hayashi K., Hatsuno K., Yoshimura R., et al. Electron Therapy for Orbital and Periorbital Lesions Using Customized lead Eye Shields. Ophthalmologica 2009, 223:96-101.
3. Brnicć Z., Vekicć B., Hebrang A., et al. Efficacy of breast shielding during CT of the head. Eur. Radiol. 2003, 13:2436-2440.
4. Beaconsfield T., Nicholson R., Thornton A., et al. Would thyroid and breast shielding be beneficial in CT of the head?. Eur. Radiol 1998, 8:664-667.
5. Hohl C., Mahnken A.H., Klotz E., et al. Radiation dose reduction to the male gonads during MDCT: The effectiveness of a lead shield. AJR Am. J. Roentgenol. 2005, 184:128-130.
6. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann. ICRP. 2007, 37:1-332. ICRP.
7. Jacobsen K.D., Olsen D.R., Fossa K., Fossa S.D. External beam abdominal radiotherapy in patients with seminoma stage I: Field type, testicular dose and spermatogenesis. Int. J. Radiat. Oncol. Biol. Phys. 1997, 38:95-102.
8. Boehmer D., Badakhshi H., Kuschke W., et al. Testicular dose in prostate cancer radiotherapy: Impact on impairment of fertility and hormonal function. Strahlenther. Onkol. 2005, 181:179-184.
9. Daniell H.W., Tam E.W. Testicular atrophy in therapeutic orchiectomy specimens from men with prostate carcinoma: Association with prior prostate bed radiation and older age. Cancer 1998, 83:1174-1179.
10. Nazmy M.S., El-Taher M.M., Attalla E.M., et al. Shielding for Scattered Radiation to the Testis during Pelvic Radiotherapy: Is it worth?. J. Egypt. Natl Cancer Inst. 2007, 19:127-132.
11. Bierri S., Rouzaud M., Mirabell R. Seminoma of the testis: Is scrotal shielding necessary when radiotherapy is limited to the para-arotic nodes?. Radiother. Oncol. 1999, 50:349-353.
12. Bobka M.S. The 21 CFR (Code of Federal Regulations) online database: Food and Drug Administration regulations full-text. Med. Ref. Serv. Q. 1993, 12:7-15.
13. Schreiner L.J., Roger M., Salomons G.J., et al. Metal artifacts supresssion megavoltage computed tomography. J. Med. Imaging 2005, 5745:637-645.
14. Hong T.S., Welsh J.S., Ritter M.A., et al. Megavoltage computed tomography: An emerging tool for image-guided radiotherapy. Am. J. Clin. Oncol. 2007, 30:617-623.
15. Rong Y., Fahner T., Welsh J.S. Hypofractionated Breast and Chest Wall Irradiation using Simultaneous In-field Boost IMRT Delivered via Helical Tomotherapy. Technol. Cancer Res. Treat. 2008, 7:433-440.
16. Kapatoes J.M., Olivera G.H., Balog J.P., et al. On the accuracy and effectiveness of dose reconstruction for tomotherapy. Phys. Med. Biol. 2001, 46:943-966.
17. Yan D., Vicini F., Wong J., et al. Adaptive radiation therapy. Phys. Med. Biol. 1997, 42:123-132.
18. Vargas C., Martinez A., Kestin L.L., et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:1297-1308.
19. Lu W., Olivera G.H., Chen Q., et al. Deformable registration of the planning image (kVCT) and the daily images (MVCT) for adaptive radiation therapy. Phys. Med. Biol. 2006, 51:4357-4374.
20. Wu C., Jeraj R., Olivera G.H., et al. Re-optimization in adaptive radiotherapy. Phys. Med. Biol. 2002, 47:3181-3195.
21. Niroomand-Rad A., Cumberlin R. Measured dose to ovaries and testes from Hodgkin's fields and determination of genetically significant dose. Int. J. Radiat. Oncol. Biol. Phys. 1993, 25:745-751.
22. Fraass B.A., Kinseela T.J., Harrington F.S., et al. Peripheral dose to the testes: The design and clinical use of a practical and effective gonal shield. Int. J. Radiat. Oncol. Biol. Phys. 1985, 11:609-615.
23. Yang C., Liu T., Jennelle R.L., et al. Utility of megavoltage fan-beam CT for treatment planning in a head-and-neck cancer patient with extensive dental fillings undergoing helical tomotherapy. Med. Dosim 2010, 35:108-114.
24. Meeks S., Langen K., Wagner T., et al. The use of MVCT images for dose calculation in the presence of metallic objects. Med. Phys. 2005, 32:2115.